glutamine has been researched along with Prodromal Characteristics in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, ML; Lai, MW; Liang, KH; Lin, WR; Lin, YH; Lo, CJ; Yeh, CT | 1 |
Long, JD; Paulsen, JS; Smith, MM | 1 |
Abe, O; Aoki, Y; Gonoi, W; Inoue, H; Iwashiro, N; Kasai, K; Katsura, M; Koike, S; Natsubori, T; Sasaki, H; Takano, Y; Takao, H; Yahata, N; Yamasue, H | 1 |
Akhadov, TA; Kaleda, VG; Keshishyan, RA; Lebedeva, IS; Menschikov, PE; Omelchenko, MA; Semenova, NA; Ublinskiy, MV; Varfolomeev, SD | 1 |
4 other study(ies) available for glutamine and Prodromal Characteristics
Article | Year |
---|---|
Plasma phenylalanine and glutamine concentrations correlate with subsequent hepatocellular carcinoma occurrence in liver cirrhosis patients: an exploratory study.
Topics: Age Factors; Aged; Area Under Curve; Carcinoma, Hepatocellular; Chromatography, Liquid; Cross-Sectional Studies; Disease Progression; Female; Glutamine; Humans; Liver Cirrhosis; Male; Middle Aged; Nuclear Magnetic Resonance, Biomolecular; Phenylalanine; Prodromal Symptoms; Prospective Studies; Risk; ROC Curve | 2020 |
Cognitive decline in prodromal Huntington Disease: implications for clinical trials.
Topics: Adult; Clinical Trials as Topic; Cognition Disorders; Disease Progression; DNA Mutational Analysis; Feasibility Studies; Female; Genetic Testing; Glutamine; Humans; Huntington Disease; Longitudinal Studies; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Outcome Assessment, Health Care; Prodromal Symptoms; Trinucleotide Repeat Expansion | 2013 |
Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.
Topics: Adolescent; Adult; Aspartic Acid; Chronic Disease; Disease Progression; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prefrontal Cortex; Prodromal Symptoms; Psychotic Disorders; Risk; Schizophrenia; Young Adult | 2014 |
(1)H-MRS and MEGA-PRESS pulse sequence in the study of balance of inhibitory and excitatory neurotransmitters in the human brain of ultra-high risk of schizophrenia patients.
Topics: Adolescent; Adult; Creatine; Frontal Lobe; Functional Laterality; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Male; Prodromal Symptoms; Proton Magnetic Resonance Spectroscopy; Risk; Schizophrenia; Young Adult | 2016 |